Using a graph of the abnormal predictive value versus the positive predictive value for the determination of outlier laboratories in the National Health Service cervical screening programme

被引:8
|
作者
Blanks, R. G. [1 ]
机构
[1] Inst Canc Res, Canc Screening Evaluat Unit, Sutton SM2 5NG, Surrey, England
关键词
cervical screening; cytology; positive predictive value; abnormal predictive value; performance measures;
D O I
10.1111/j.1365-2303.2010.00771.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Using a graph of the abnormal predictive value versus the positive predictive value for the determination of outlier laboratories in the National Health Service cervical screening programme Objective: The positive predictive value (PPV) for the detection of cervical intraepithelial neoplasia (CIN) grade 2 or worse of referral to colposcopy from moderate dyskaryosis or worse (equivalent to high-grade squamous intraepithelial lesion or worse) is a standard performance measure in the National Health Service cervical screening programme. The current target is to examine 'outlier' laboratories with PPVs outside the 10th-90th percentile, which automatically identifies 20% of laboratories for further investigation. A more targeted method of identifying outliers may be more useful. Methods: A similar measure to the PPV, the abnormal predictive value (APV), can be defined as the predictive value for CIN2 or worse for referrals from borderline (includes atypical squamous and glandular cells) and mild dyskaryosis (equivalent to low-grade squamous intraepithelial lesion) combined. A scatter plot of the APV versus the PPV can be produced (the APV-PPV diagram). Three kinds of 'outlier' can be defined on the diagram to help determine laboratories with unusual data. These are termed a true outlier value (TOV) or an extreme value (EV) for either PPV or APV, or a residual extreme value (REV) from the APV-PPV best line of fit. Results: Using annual return information for 2007/8 from 124 laboratories, two were defined as having EVs for PPV (both had a relatively low PPV of 62%). For APV, four laboratories were considered to have EVs of 34%, 34%, 34% and 4% and one was considered to be a TO with an APV of 45%. Five were identified as REV laboratories, although three of these were also identified as having extreme or outlier values, leaving two that had not been identified by the other methods. A total of eight (6%) laboratories were therefore identified as meriting further investigation using this methodology. Conclusions: The method proposed could be a useful alternative to the current method of identifying outliers. Slide exchange studies between the identified laboratories, particularly those at opposing ends of the diagram, or other further investigations of such laboratories, may be instructive in understanding why such variation occurs, and could therefore potentially, lead to improvements in the national programme.
引用
收藏
页码:379 / 388
页数:10
相关论文
共 28 条
  • [1] Comparison of SurePath® and ThinPrep® liquid-based cervical cytology using positive predictive value, atypical predictive value and total predictive value as performance indicators
    Wright, P. K.
    Marshall, J.
    Desai, M.
    CYTOPATHOLOGY, 2010, 21 (06) : 374 - 378
  • [2] Should a standard be defined for the Positive Predictive Value (PPV) of recall in the UK NHS Breast Screening Programme?
    Bennett, R. L.
    Blanks, R. G.
    BREAST, 2007, 16 (01): : 55 - 59
  • [3] Estimating the positive predictive value of opportunistic population testing for gonorrhoea as part of the English Chlamydia Screening Programme
    Fowler, T.
    Edeghere, O.
    Inglis, N.
    Bradshaw, S.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2013, 24 (03) : 185 - 191
  • [4] Determination of whether screening tests for chronic atrophic gastritis really has a positive predictive value
    Di Paola, Flaviano
    D'Angelo, Valentina
    Tatangelo, Fabiana
    Barchiesi, Vittoria
    Rizzo, Marianna
    Cantile, Monica
    Botti, Gerardo
    Cavalcanti, Ernesta
    MOLECULAR MEDICINE REPORTS, 2015, 12 (03) : 3521 - 3524
  • [5] SCREENING MAMMOGRAPHY IN COMMUNITY PRACTICE - POSITIVE PREDICTIVE VALUE OF ABNORMAL FINDINGS AND YIELD OF FOLLOW-UP DIAGNOSTIC PROCEDURES
    BROWN, ML
    HOUN, F
    SICKLES, EA
    KESSLER, LG
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1995, 165 (06) : 1373 - 1377
  • [6] PERFORMANCE OF THE UK NEWBORN SCREENING PROGRAMME FOR CF, WHICH INCORPORATES STRATEGIES TO IMPROVE POSITIVE PREDICTIVE VALUE AND REDUCE CARRIER RECOGNITION
    Southern, K. W.
    Morgan, T.
    Kour, S.
    Scott, E.
    Coppinger, C.
    Cavanagh, C.
    Winters, V
    Sinclair, D.
    Pollittt, R.
    Elliman, D.
    Doull, I
    Desai, M.
    Price, J.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 382 - 383
  • [7] Positive Predictive Value of the Expression of HPV Oncogenic Proteins E6 and E7 in Cervical Cancer Screening
    Rongioletti, Mauro
    Papa, Fabrizio
    Panetta, Valentina
    Vaccarella, Cizia
    Rasulo, Umberto
    Di Stefano, Sandra
    Mari, Roberto
    Selvaggini, Serena
    D'Andrea, Barbara
    Cesaretti, Simona
    Liumbruno, Giancarlo Maria
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (04) : 633 - 633
  • [8] Positive predictive value of a register-based algorithm using the Danish National Registries to identify suicidal events
    Gasse, Christiane
    Danielsen, Andreas Aalkjaer
    Pedersen, Marianne Giortz
    Pedersen, Carsten Bocker
    Mors, Ole
    Christensen, Jakob
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (10) : 1131 - 1138
  • [9] Improving the Sensitivity and Positive Predictive Value in a Cystic Fibrosis Newborn Screening Program Using a Repeat Immunoreactive Trypsinogen and Genetic Analysis
    Sontag, Marci K.
    Lee, Rachel
    Wright, Daniel
    Freedenberg, Debra
    Sagel, Scott D.
    JOURNAL OF PEDIATRICS, 2016, 175 : 150 - +
  • [10] Detecting and staging podoconiosis cases in North West Cameroon: positive predictive value of clinical screening of patients by community health workers and researchers
    Wanji, Samuel
    Kengne-Ouafo, Jonas A.
    Datchoua-Poutcheu, Fabrice R.
    Njouendou, Abdel Jelil
    Tayong, Dizzel Bita
    Sofeu-Feugaing, David D.
    Amvongo-Adjia, Nathalie
    Fovennso, Bridget A.
    Longang-Tchounkeu, Yolande F.
    Tekola-Ayele, Fasil
    Enyong, Peter A.
    Newport, Melanie J.
    Davey, Gail
    BMC PUBLIC HEALTH, 2016, 16